Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,120.2
1.5 (0.05%)

 

  • STI Straits Times Index
    3,120.2
    1.5 (0.05%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,558.5
    -6.3 (-0.40%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,846.5
    29.4 (0.10%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,561.7
    -4.5 (-0.13%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,858.2
    -16.7 (-0.06%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,015.0
    -19.5 (-0.32%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 686.7M
  • Value: 486.1M
  • Rise: 141
  • Fall: 145
  • Unch: 478

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.006-
Tuan Sing0.545+0.070
MarcoPolo Marine0.028-
AP Strategic0.002-
YZJ Shipbldg SGD1.400+0.020
Trendlines0.114+0.003
Rex Intl0.189+0.004
Singtel2.320+0.020
Adventus0.011-0.001
Intl Cement0.035+0.001

World Indices

World Indices
Name Last Change
Nasdaq 14,271.7 +18.5
HSI 28,846.5 +29.4
HSCEI 10,674.8 +0.9
Jakarta 6,015.0 -19.5
Nikkei 225 28,858.1 -16.8
SSE Comp 3,561.9 -4.3
Shanghai A 3,733.5 -4.6
Shanghai B 253.3 +1.6
KOSPI 3,282.7 +6.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

VALNEVA SE SPON ADS EACH REPR 2 ORD SHS VALNEVA SE SPONSORED ADR
Updated on 23 Jun 2021 (End of trading day)
Last (USD): 25.990 Change: -0.110 High: 26.000 Remarks: -
Change (%): -0.42 Low: 25.460
Open 25.631 Yesterday's Close 26.099999999999998
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 3,805 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.46977 Trailing EPS (USD) e -2.11421 NAV (USD) b 1.2320
PE a - Trailing PE f - Price / NAV b 21.0958
Dividend (USD) d - Cash In Hand (USD) g 5.5516 Issued & Paid-up Shares c 49,944,200
Dividend Yield (%) d - Price / Cash In Hand g 4.682 Treasury Shares h -
Market Cap (M) 1,298.050 Enterprise Value (M) 1,145.373
Piotroski F Score 3 Exchange Code VALN Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 04 May 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference VALNEVA SE SPON ADS EACH REPR 2 ORD SHS NASDAQ 1,298.050 - - 21.0958 -
Industry Biotechnology NASDAQ 3,091.437 106.306 106.381 6.7145 0.565
Local Peer AMGEN INC NASDAQ 137,151.785 18.881 19.358 14.6938 2.699
Local Peer MODERNA INC NASDAQ 85,139.997 - 142.335 22.1834 -
Local Peer GILEAD SCIENCES INC NASDAQ 83,591.097 679.617 277.711 4.4107 4.080
Local Peer ILLUMINA INC NASDAQ 68,492.980 104.410 108.719 13.9157 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 55,429.069 3,199.498 38.135 18.7179 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 56,446.995 16.067 14.098 4.7129 -
Local Peer BIOGEN INC NASDAQ 55,991.404 13.996 18.591 5.2416 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 48,542.552 17.901 17.575 5.4055 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 39,745.847 65.870 58.295 3.2010 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 31,559.321 - - 7.8825 -
Local Peer SEAGEN INC NASDAQ 28,470.112 46.393 43.094 8.3134 -
Local Peer EXACT SCIENCES CORP NASDAQ 22,468.034 - - 6.1573 -
Other Local Peers 10X GENOMICS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), BIO-TECHNE CORP (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), NOVAVAX INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACCELERON PHARMA (NASDAQ), EXELIXIS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), LYELL IMMUNOPHARMA INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALKERMES PLC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), FIBROGEN INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), EDITAS MEDICINE INC (NASDAQ), INSTIL BIO INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), XENCOR INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), SEER INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ALECTOR INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CORTEXYME INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), REGENXBIO INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), TRANSLATE BIO INC (NASDAQ), OCUGEN INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), MACROGENICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), ALLOVIR INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), BIOATLA INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), IMMUNOGEN INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), NAUTILUS BIOTECHNOLOGY INC (NASDAQ), AGENUS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), PERSONALIS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), VAXCYTE INC (NASDAQ), HUMANIGEN INC (NASDAQ), IMMUNOVANT INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), VAXART INC (NASDAQ), OMEROS CORP (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), INHIBRX INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), NKARTA INC (NASDAQ), JANUX THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), PASSAGE BIO INC (NASDAQ), IMMATICS N V (NASDAQ), SESEN BIO INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARDELYX INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), CHIMERIX INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), COMPUGEN (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MOLECULAR PARTNERS AG SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ALTIMMUNE INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), GERON CORP (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), AKOUOS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ONCORUS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), AVROBIO INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), BIOVIE INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), VERA THERAPEUTICS INC. (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), ATHERSYS INC (NASDAQ), ATRECA INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), TREVENA INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ADICET BIO INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), KAMADA LTD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), INMUNE BIO INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CHIASMA INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), NEXTCURE INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), IMMUNOME INC (NASDAQ), MEDICINOVA INC (NASDAQ), SAVARA INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), CABALETTA BIO INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), LONGEVERON INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), INFLARX N V (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), METACRINE INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), BIOCARDIA INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), COHBAR INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ADVAXIS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), HISTOGEN INC (NASDAQ), SOLIGENIX INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ZIVO BIOSCIENCE INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), GEOVAX LABS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PALISADE BIO INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 18.421 13.9429 2.837
Global Peer CSL LTD ASX 133,919.354 42.700 35.188 12.6729 0.997
Global Peer WUXI BIO HKEx 581,942.009 306.643 306.642 23.8676 -
Global Peer BEIGENE HKEx 245,518.336 - - 7.8880 -
Global Peer SINO BIOPHARM HKEx 145,552.901 46.743 32.593 6.5750 0.946
Global Peer ZAI LAB-SB HKEx 118,639.929 - - 15.1141 -
Global Peer GENSCRIPT BIO HKEx 72,853.639 - - 10.4201 -
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer JOINN HKEx 35,732.683 100.946 161.451 4.5667 0.266
Global Peer 3SBIO HKEx 30,787.813 32.782 32.782 2.4293 -
Other Global Peers VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), KINTOR PHARMA-B (HKEx), JACOBIO-B (HKEx), FRONTAGE (HKEx), NUVATION BIO INC (NYSE), MYOVANT SCIENCES LTD (NYSE), HAOHAI BIOTEC (HKEx), JW THERAP-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), ASCENTAGE-B (HKEx), POLYNOVO LIMITED (ASX), IMUGENE LIMITED (ASX), TELIX PHARMACEUTIC (ASX), MESOBLAST LTD (ASX), JHBP-B (HKEx), ACTINIUM PHARMACEUTICALS INC (NYSE American), AMBRX BIOPHARMA INC SPON ADS EACH REP 7 ORD SHS (NYSE), DPHARMA (Bursa), ESSEX BIO-TECH (HKEx), ASCLETIS-B (HKEx), 22ND CENTURY GROUP INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), SINOMAB BIO-B (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), OPTHEA LIMITED (ASX), LEE'S PHARM (HKEx), IMMUTEP LTD (ASX), ANTEOTECH LIMITED (ASX), NANOVIRICIDES INC (NYSE American), NEXT SCIENCE LTD (ASX), CEL-SCI CORP (NYSE American), ACTINOGEN MEDICAL LTD (ASX), BIONOMICS LTD (ASX), ENZO BIOCHEM INC (NYSE), IBIO INC (NYSE American), LEAF RESOURCES LTD (ASX), BIOMX INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), NEUREN PHARMACEUTICALS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), UNI-BIO GROUP (HKEx), SYNTHETIC BIOLOGICS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CHIMERIC THERAPEUTICS LTD (ASX), PATRYS LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), CT ENTERPRISE (HKEx), GENETIC TECHNOLOGIES (ASX), REGENT PACIFIC (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), MEMPHASYS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TERRAGEN HOLDINGS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), ORAGENICS INC (NYSE American), Suntar Eco-City (SGX), RHINOMED LIMITED (ASX), BIOTRON (ASX), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), BIOSINO BIO-TEC (HKEx), AMPLIA THERAPEUTICS LTD (ASX), REGENEUS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), CRYOSITE (ASX),